Evaluation of Vancomycin Dose Needed to Achieve 24-Hour Area Under the Concentration-Time Curve to Minimum Inhibitory Concentration Ratio Greater Than or Equal to 400 Using Pharmacometric Approaches in Pediatric Intensive Care Patients.

Autor: Jung D; Center for Translational Medicine, University of Maryland School of Pharmacy, Baltimore, MD., Kishk OA; Department of Pharmacy, University of Maryland Medical Center, Baltimore, MD.; U.S. Food and Drug Administration, Center for Drug Evaluation and Research, Office of Surveillance and Epidemiology, Silver Spring, MD., Bhutta AT; Division of Pediatric Critical Care Medicine, Department of Pediatrics, University of Maryland School of Medicine, Baltimore, MD.; Pediatric Critical Care Medicine, Indiana University School of Medicine/Riley Children's Health, Indianapolis, IN., Cummings GE; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD., El Sahly HM; Departments of Molecular Virology and Microbiology and Medicine, Baylor College of Medicine, Houston, TX., Virk MK; Department of Pediatrics, Section of Critical Care Medicine, Texas Children's Hospital Baylor College of Medicine, Houston, TX., Moffett BS; Department of Pharmacy, Texas Children's Hospital, Houston, TX.; Department of Pediatrics, Baylor College of Medicine, Houston, TX.; Medical Science Liaison, Novartis, Houston, TX., Morris Daniel JL; Department of Pharmacy, Texas Children's Hospital, Houston, TX.; Department of Pediatrics, Baylor College of Medicine, Houston, TX.; Imagine Pediatrics, Houston, TX., Watanabe A; The Emmes Company, LLC, Rockville, MD., Fishbane N; The Emmes Company, LLC, Rockville, MD., Kotloff KL; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD., Gu K; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD., Ghazaryan V; Division of Microbiology and Infectious Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, MD., Gobburu JVS; Center for Translational Medicine, University of Maryland School of Pharmacy, Baltimore, MD., Akcan-Arikan A; Divisions of Critical Care Medicine and Nephrology, Department of Pediatrics, Texas Children's Hospital Baylor College of Medicine, Houston, TX., Campbell JD; Department of Pediatrics, Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD.

Publikováno v: Critical care explorations [Crit Care Explor] 2024 Oct 01; Vol. 6 (10), pp. e1159. Date of Electronic Publication: 2024 Oct 01 (Print Publication: 2024).